CIK 0001933567
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Neuraxis, INC
Sign in to watch- Ticker
- NRXS
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455079684
- Phone
- +1 812-689-0791
- Business address
- 11611 N. MERIDIAN ST, SUITE 330, CARMEL, IN, 46032
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Open-market buy Chief Executive Officer bought 268 shares at $4.84 ($1,297)
- 4 Open-market buy CRO, CCO, CPO bought 328 shares at $4.84 ($1,588)
- 4 Open-market buy Chief Financial Officer bought 1,937 shares at $4.84 ($9,375)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CRO, CCO, CPO acquired 193,678 shares (grant or award)
- 4 Grant or award CMO, SVP Science & Tech acquired 199,106 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 199,188 shares (grant or award)
- 8-K Event Executive or director change · Other events
- 4 Grant or award Director acquired 26,073 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 26,073 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 31,134 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 86,224 shares (grant or award)
Page 1 of 10 · 196 filings